In humans, DCP2 is upregulated in lung cancer (Watson et al., 2008) and regulates histone mRNA titres (Mullen and Marzluff 2008) and there is some evidence that DCP2 is regulated by the p53-DREAM pathway (Engeland 2018). This evidence concerns the gene DCP2 and lung carcinoma.